i-SENS, Inc. (KOSDAQ:099190)
16,190
-310 (-1.88%)
Nov 7, 2025, 3:30 PM KST
i-SENS Market Cap
i-SENS has a market cap or net worth of 446.62 billion as of November 7, 2025. Its market cap has decreased by -7.65% in one year.
Market Cap
446.62B
Enterprise Value
540.76B
Revenue
305.89B
Ranking
n/a
PE Ratio
230.68
Stock Price
16,190.00
Market Cap Chart
Since January 30, 2013, i-SENS's market cap has increased from 232.76B to 446.62B, an increase of 91.88%. That is a compound annual growth rate of 5.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2025 | 455.17B | 7.85% |
| Dec 30, 2024 | 422.03B | -46.36% |
| Dec 28, 2023 | 786.74B | 74.15% |
| Dec 29, 2022 | 451.77B | 9.85% |
| Dec 30, 2021 | 411.25B | 0.83% |
| Dec 30, 2020 | 407.85B | 16.73% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.49T |
| ALTEOGEN | 29.25T |
| SK Biopharmaceuticals | 9.36T |
| Yuhan | 8.57T |
| HLB Co., Ltd. | 7.14T |
| Peptron | 5.88T |
| ABL Bio | 5.72T |